Uncovering the roots of Parkinson's disease, together
A global basic research initiative
Aligning Science Across Parkinson’s (ASAP) is fostering collaboration and resources to better understand the underlying causes of Parkinson’s disease. With scale, transparency, and open access data sharing, we believe we can accelerate the pace of discovery, and inform the path to a cure.
GP2 Launches Monogenic Hub
Through GP2’s Monogenic Hub, clinicians and researchers from around the world have the opportunity to submit data, access statistics, and learn more about ways to contribute to the investigation of people with Parkinson’s who potentially have a monogenic cause. The Monogenic Hub is also used to collect the results of genetics studies as well as anonymized global and aggregated data from other GP2 participating centers.
Closing the Equity Gap in Parkinson's Research
To date, around 90% of global genetic studies in the Parkinson’s disease field have been performed on European ancestry populations. Our pioneering BLAAC PD study, launched this year, is committed to assessing the diverse aspects of Parkinson’s disease within underrepresented communities by advancing research that includes Black and African American participants. Read GP2’s latest blog post to learn more.
GP2 Launches Training Platform
GP2’s new online learning platform makes development opportunities accessible and enables learners from around the world to explore courses on topics related to Parkinson’s disease genetics and a range of related areas. It is easy to register and available to everyone interested.
ASAP, through GP2 and in partnership with LARGE-PD and the MJFF, celebrated a shared milestone with the inauguration of the DNA Biobank at the Instituto Nacional de Ciencias Neurológicas. The Biobank will help accelerate collaboration and greater genetic representation of Latin American participants in research.